Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru.

BACKGROUND:Nearly half of the world's population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection...

Full description

Bibliographic Details
Main Authors: Brett M Forshey, Robert C Reiner, Sandra Olkowski, Amy C Morrison, Angelica Espinoza, Kanya C Long, Stalin Vilcarromero, Wilma Casanova, Helen J Wearing, Eric S Halsey, Tadeusz J Kochel, Thomas W Scott, Steven T Stoddard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-02-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4746126?pdf=render